¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-05-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-05-28
±³À°ÀÏÀÚ : 2021-05-28
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁ¹ê¼ÇȦ,´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2021 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ
´ã´çÀÚ : °íÀº¾ç
¿¬¶ôó : 051-255-6902  
À̸ÞÀÏ : sericonf@daum.net      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ 09:30~09:50 Understanding of medically unexplained symptoms  ¹ÚÇý¿¬(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ 09:50~10:10 Diagnosis and evaluation of somatic symptom disorder  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ 10:10~10:30 Management of somatic symptom disorder  ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë) 
Åä·Ð 05-28 Ä˺¥¼ÇȦ 10:30~10:40 Q & A  () 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ 10:50~11:15 Psychotic disorders due to medical illnesses  ±è¼º¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ 11:15~11:40 Mood disorders due to medical illnesses  ÃÖ°ü¿ì(°í·ÁÀÇ´ë) 
Åä·Ð 05-28 Ä˺¥¼ÇȦ 11:40~11:50 Q & A  () 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ/´ëȸÀǽǠ12:00~12:20 A retrospective study of the effect of background factors on seizure quality in ECT,  Nobuatsu Aoki(Department of Neuropsychiatry Kansai Medical University) 
±³À°½Ã°£ 05-28 Ä˺¥¼ÇȦ/´ëȸÀǽǠ12:20~12:40 Serum CK levels in 72 patients with malignant syndrome, rhabdomyolysis, and water intoxication  Hidenori Matsunaga(Division of PsychiatryOsaka General Medical Center) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 12:50~13:15 Psychedelic Drugs: Lessons From SPRAVATO  À̹®¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 13:15~13:40 SPRAVATO clinical ting &real practice for TRD/MDSI patients  °­¿ø¼·(°æÈñÀÇ´ë) 
Åä·Ð 05-28 ÄÁº¥¼ÇȦ 13:40~13:50 Q&A  () 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 14:00~14:25 Effects of contraception on psychiatric problem  À±¼­¿µ(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 14:25~14:50 Hormonal background and treatment of perinatal depression  ±è¼±¹Ì(Áß¾Ó´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 14:50~15:15 Cognition and mood in perimenopausal women  À̼ÒÈñ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
Åä·Ð 05-28 ÄÁº¥¼ÇȦ 15:15~15:30 Q & A  () 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 15:50~16:15 EAP »ç¾÷ÀÇ ¿î¿µ °æÇè°ú ½ÇÁ¦  ±èÁ¤Çö(ºÐ´ç ¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 16:15~16:40 Á÷ÀåÀÎ Á¤½Å°Ç°­°ü¸®ÀÇ ½ÇÁ¦ : °ø°ø Á¤½Å º¸°Ç ¿µ¿ªÀ» Áß½ÉÀ¸·Î  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 05-28 ÄÁº¥¼ÇȦ 16:40~17:05 ±â¾÷ÀÇ Á÷ÀåÁ¤½Å°Ç°­ °ü¸® ¹æ¾ÈÀÇ ½ÇÁ¦  Àü»ó¿ø(°­ºÏ»ï¼ºº´¿ø ±â¾÷Á¤½Å°Ç°­¿¬±¸¼Ò) 
Åä·Ð 05-28 ÄÁº¥¼ÇȦ 17:05~17:20 Q & A  () 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ12:50~13:15 Differential Benefits of BUSPAR  È«Á¤¿Ï(Àͻ꺴¿ø) 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ13:15~13:40 The usefulness of buspirone in treatment somatic symptoms  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
Åä·Ð 05-28 ´ëȸÀǽǠ13:40~13:50 Q&A  () 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ14:00~14:25 Cancer mortality  ±èÇöÁø(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ14:25~14:50 Drug-related mortality in psychiatric patients  ±è±â¿ø(Áß¾Óº¸Èƺ´¿ø) 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ14:50~15:15 Mortality in schizophrenia and bipolar disorder  ±èÁØÇü(°í·ÁÀÇ´ë) 
Åä·Ð 05-28 ´ëȸÀǽǠ15:15~15:30 Q & A  () 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ15:50~16:15 Àü°øÀÇ Âü¿© º´µ¿consult¿¡¼­ÀÇ Å¸°ú¿ÍÀÇ ÀÇ»ç¼ÒÅë  ±èż®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ16:15~16:40 ÀÀ±Þ½Ç¿¡¼­ÀÇ Å¸°ú¿ÍÀÇ ÀÇ»ç ¼ÒÅë  ÃÖÀç¿ø(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-28 ´ëȸÀǽǠ16:40~17:05 ¹Ù²î´Â ¼ö·Ãȯ°æ ÇÏ¿¡¼­ ÇÊ¿äÇÑ Àü°øÀÇ ¼ö·Ã ¹æ½Ä º¯È­  ¿ÀÈ«¼®(°Ç¾ç´ë) 
Åä·Ð 05-28 ´ëȸÀǽǠ17:05~17:20 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-05-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û KSSS 2021 ±¹Á¦Çмú´ëȸ (ÇÏÀ̺긮µå °³ÃÖ) 1ÀÏÂ÷ : 2021-05-28
´ÙÀ½±Û (¿Â¶óÀÎ) °æºÏ´ëÇб³ ¾È°úÇб³½Ç ¸ñ¿ä Áý´ãȸ : 2021-05-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21182 °æ±â Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ) : 2024-07-26 0 20 2024-07-02
21181 ´ë±¸ Çѱ¹¿©ÀÚÀÇ»çȸ ´ë±¸°æºÏÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(ºÒ¸éÁõ, ¼ö¸éÁ¦, Ȳ¹Ýº¯¼º ¹× ³ëÈ­ °ü·Ã ¾ÈÁúȯ) : 2024-07-23 0 25 2024-07-02
21180 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø (¿Â¶óÀÎ) Á¦12ȸ ¼­¿ï ÀÓ»ó¾îÁö·³Áõ ¼¼¹Ì³ª : 2024-07-21 0 32 2024-07-02
21179 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ÇнÀÀå¾Ö ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-07-21 0 40 2024-07-02
21178 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú½ºÆ÷Ã÷ÀÇÇÐȸ - Á¦2Â÷ ½ºÆ÷Ã÷ ¼Õ»ó ½ÉÆ÷Áö¾ö : 2024-07-21 0 24 2024-07-02
21177 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (2ÀÏÂ÷) : 2024-07-20 0 22 2024-07-02
21176 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦2ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-07-20 0 21 2024-07-02
21175 ¼­¿ï 21st Head and Neck Workshop (»ï¼º¼­¿ïº´¿ø & ´ëÇѵΰæºÎ¿Ü°úÇÐȸ) : 2024-07-20 0 24 2024-07-02
21174 ¼­¿ï 2024 ´ëÇÑÈ£Èí°ü¸®ÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2024-07-20 0 20 2024-07-02
21173 ¼­¿ï 2024³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº¿¬±¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-07-20 0 23 2024-07-02
21172 ¼­¿ï Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20 0 21 2024-07-02
21171 ¼¼Á¾ 2024³â ´ëÇÑ°í°üÀýÇÐȸ °üÀýº¸Á¸ ½ÉÆ÷Áö¿ò : 2024-07-20 0 28 2024-07-02
21170 ¿ï»ê 2024³â Á¦7ȸ ´ëÇÑÇ׳ëÈ­ºñ´¢ÅëÇÕ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-20 0 26 2024-07-02
21169 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (1ÀÏÂ÷) : 2024-07-19 0 26 2024-07-02
21168 ¼­¿ï ´ëÇÑ»çȸÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-19 0 36 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷